Assessment of the Impact of Dexmedetomidine on Myocardial Injury in TAVI Patients: A Retrospective Cohort Study Utilizing PSM-DID
Dexmedetomidine administration during TAVI was associated with reduced levels of myocardial injury markers, indicating a potential cardioprotective role. By reducing myocardial injury, DEX may contribute to improved perioperative outcomes, including a decreased risk of major adverse postoperative events. These results highlight the potential clinical utility of DEX in the perioperative management of TAVI patients, suggesting that its inclusion in anesthetic protocols could enhance patient care and recovery.
Authors
- Huiping Xu (ORCID: https://orcid.org/0000-0002-4025-6401)
- Shaolin Wang (ORCID: https://orcid.org/0000-0003-0866-4584)
- Yong Q. Chen (ORCID: https://orcid.org/0000-0003-4747-4708)
- Jin Zhang (ORCID: https://orcid.org/0009-0005-6336-6354)
- Hao Cheng (ORCID: https://orcid.org/0009-0001-7585-0507)
- Song Yang (ORCID: https://orcid.org/0000-0002-7792-5752)
- C. Gui (ORCID: https://orcid.org/0009-0008-9517-2935)
Institutions
- Wannan Medical College (CN)
- Wuhu Fourth People Hospital (CN)
- Wuhu No 1 People's Hospital (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/tcrm.s507439
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00